<html>
<head>PUBMED IDs for CANT1</head>
<body bgcolor='#C5F0F2'><h1>CANT1</h1><a href='https://pubmed.ncbi.nlm.nih.gov/18451133/'>Two unique novel prostate-specific and androgen-regulated fusion partners of ETV4 in prostate cancer.</a> May 3  2008<br><a href='https://pubmed.ncbi.nlm.nih.gov/18794152/'>A fluorescence in situ hybridization screen for E26 transformation-specific aberrations: identification of DDX5-ETV4 fusion protein in prostate cancer.</a> September 17  2008<br><a href='https://pubmed.ncbi.nlm.nih.gov/19853239/'>Identification of CANT1 mutations in Desbuquois dysplasia.</a> December 23  2009<br><a href='https://pubmed.ncbi.nlm.nih.gov/20425819/'>Mutation of CANT1 causes Desbuquois dysplasia.</a> August 13  2010<br><a href='https://pubmed.ncbi.nlm.nih.gov/21037275/'>CANT1 mutation is also responsible for Desbuquois dysplasia, type 2 and Kim variant.</a> June 11  2010<br><a href='https://pubmed.ncbi.nlm.nih.gov/21435463/'>The androgen-regulated Calcium-Activated Nucleotidase 1 (CANT1) is commonly overexpressed in prostate cancer and is tumor-biologically relevant in vitro.</a> July 16  2011<br><a href='https://pubmed.ncbi.nlm.nih.gov/21654728/'>Desbuquois dysplasia type I and fetal hydrops due to novel mutations in the CANT1 gene.</a> February 15  2011<br><a href='https://pubmed.ncbi.nlm.nih.gov/22539336/'>Further delineation of CANT1 phenotypic spectrum and demonstration of its role in proteoglycan synthesis.</a> December 10  2012<br><a href='https://pubmed.ncbi.nlm.nih.gov/24755949/'>Expanding the clinical spectrum of B4GALT7 deficiency: homozygous p.R270C mutation with founder effect causes Larsen of Reunion Island syndrome.</a> August 6  2014<br><a href='https://pubmed.ncbi.nlm.nih.gov/25252066/'>Case of Desbuquois dysplasia type 1: potentially lethal skeletal dysplasia.</a> September 7  2014<br><a href='https://pubmed.ncbi.nlm.nih.gov/25486376/'>A novel CANT1 mutation in three Indian patients with Desbuquois dysplasia Kim type.</a> December 15  2014<br><a href='https://pubmed.ncbi.nlm.nih.gov/27881841/'>Novel and recurrent XYLT1 mutations in two Turkish families with Desbuquois dysplasia, type 2.</a> November 25  2016<br></body></html>
